• 1
    Brook I. Anaerobic infections: diagnosis and management, 1st edn. New York, NY: Informa Healthcare, 2008.
  • 2
    Calvo A, Cárdenas M, Rodríguez C, Bertuglia F, Andrade O, Márquez N. Prevalencia de bacterias anaerobias y evaluación de su resistencia a los antibióticos por el método de E-test. Rev Panam Infectol 2004; 6: 1722.
  • 3
    Jousimies-Somer HR, Summanen P, Citron DM, Baron EL, Wexler HM, Finegold S. Wadsworth-KTL: anaerobic bacteriology manual, 6th edn. Belmont, CA: Star Publishing Company, 2002.
  • 4
    Brook I. Recovery of anaerobic bacteria from clinical specimens in 12 years at two military hospitals. J Clin Microbiol 1988; 26: 11811188.
  • 5
    Gubina M, Urbancic-Rovan V, Tomic V. Anaerobes isolated from clinical material over three years. Anaerobe 1997; 3: 7981.
  • 6
    Fader RC. Anaerobes of clinical importance. In: MahonCR, LehmanDC, ManuselisG, eds. Textbook of diagnostic microbiology, 4th edn. Missouri, PA: WB Saunders, 2010.
  • 7
    Polidorou F, Malaka E, Pavlitou E et al. Anaerobic bacteria in clinical infections. Anaerobe 1997; 3: 159161.
  • 8
    Jamal W, Shahin M, Rotimi VO. Surveillance and trends of antimicrobial resistance among clinical isolates of anaerobes in Kuwait hospitals from 2002 to 2007. Anaerobe 2010; 16: 15.
  • 9
    Quesada-Gómez C, Rodríguez-Cavallini E, Gamboa-Coronado MM. Bacterias anaerobias aisladas de muestras clínicas de un hospital regional de adultos de Costa Rica. Rev Biomedica 2007; 18: 8995.
  • 10
    Aldridge KE, Ashcraft D, Cambre K, Pierson CL, Jenkins SG. Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas and Peptostreptococcus species. Antimicrob Agents Chemother 2001; 45: 12381243.
  • 11
    Wexler HM. Bacteroides: the good, the bad and the nitty-gritty. Clin Microbiol Rev 2007; 20: 593621.
  • 12
    Panigrahi D, Rotimi VO, Dhar R et al. Anaerobic bacterial flora of intra-abdominal infections and their antimicrobial susceptibility pattern in Kuwait. Anaerobe 2001; 7: 291295.
  • 13
    Loivukene K, Naaber P. Antibiotic susceptibility of clinically relevant anaerobes in Estonia from 1999 to 2001. Anaerobe 2003; 9: 5761.
  • 14
    Roberts SA, Shore KP, Paviour SD, Holland D, Morris AJ. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999–2003. J Antimicrob Chemother 2006; 57: 992998.
  • 15
    Downes J, King A, Hardie J, Phillips I. Evaluation of the Rapid ID 32A system for identification of anaerobic Gram-negative bacilli, excluding the Bacteroides fragilis group. Clin Microbiol Infect 1999; 5: 319326.
  • 16
    Justesen US, Skov MN, Knudsen E, Holt HM, Søgaard P, Justesen T. 16S rRNA gene sequencing in routine identification of anaerobic bacteria isolated from blood cultures. J Clin Microbiol 2010; 48: 946948.
  • 17
    Larsson L, Holst E. Feasibility of automated head-space gas chromatography in identification of anaerobic bacteria. Acta Pathol Microbiol Immunol Scand B 1982; 90: 125130.
  • 18
    Drancourt M, Berger P, Raoult D. Systematic 16S rRNA gene sequencing of atypical clinical isolates identified 27 new bacterial species associated with humans. J Clin Microbiol 2004; 42: 21972202.
  • 19
    Fontana C, Favaro M, Pelliccioni M, Pistoia ES, Favalli C. Use of the MicroSeq 500 16S rRNA gene-based sequencing for identification of bacterial isolates that commercial automated systems failed to identify correctly. J Clin Microbiol 2005; 43: 615619.
  • 20
    Bessède E, Angla-gre M, Delagarde Y, Sep Hieng S, Ménard A, Mégraud F. Matrix-assisted laser desorption ionization Biotyper: experience in the routine of a university hospital. Clin Microbiol Infect 2010; doi: 10.1111/j.1469-0691.2010.03274.x.